Adma Biologics, Inc (ADMA) insider trading
Every open-market stock purchase and sale by Adma Biologics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $468K over the last 12 months (4 buys).
- Insiders sold $1.9M over the last 12 months (6 sales).
- Last insider buy: Jerrold B Grossman (Insider), $50.6K, 4 months ago.
Last 12 months: insiders bought $468K (4 buys) and sold $1.9M (6 sales). Last close $8.48 on Jun 10, 2026.
Recent ADMA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| May 27, 2026 | Jerrold B Grossman (Insider) | Bought | $50.6K |
| May 12, 2026 | Jerrold B Grossman (Insider) | Bought | $100K |
| May 11, 2026 | Jerrold B Grossman (Insider) | Bought | $100K |
| Apr 1, 2026 | Kaitlin M. Kestenberg-Messina (COO) | Sold (not open market) | $185K |
| Mar 17, 2026 | Lawrence P. Guiheen (Insider) | Bought (not open market) | — |
| Mar 16, 2026 | Adam S Grossman (CEO) | Sold | $227K |
| Mar 16, 2026 | Adam S Grossman (CEO) | Sold | $91K |
| Mar 16, 2026 | Adam S Grossman (CEO) | Bought (not open market) | — |
| Mar 13, 2026 | Lawrence P. Guiheen (Insider) | Bought (not open market) | — |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina (COO) | Sold | $158K |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina (COO) | Sold (not open market) | — |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina (COO) | Bought (not open market) | — |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina (COO) | Bought (not open market) | — |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina (COO) | Bought (not open market) | — |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina (COO) | Bought (not open market) | — |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina (COO) | Bought (not open market) | — |
| Mar 7, 2026 | Adam S Grossman (CEO) | Sold (not open market) | $454K |
| Mar 7, 2026 | Kaitlin M. Kestenberg-Messina (COO) | Sold (not open market) | $65.2K |
| Mar 6, 2026 | Adam S Grossman (CEO) | Sold (not open market) | $869K |
| Mar 6, 2026 | Kaitlin M. Kestenberg-Messina (COO) | Sold (not open market) | $155K |
| Mar 6, 2026 | Steve Elms (Insider) | Bought | $108K |
| Mar 5, 2026 | Steve Elms (Insider) | Bought | $110K |
| Feb 26, 2026 | Adam S Grossman (CEO) | Sold (not open market) | $833K |
| Feb 19, 2026 | Adam S Grossman (CEO) | Sold (not open market) | $405K |
| Feb 19, 2026 | Kaitlin M. Kestenberg-Messina (COO) | Sold (not open market) | $133K |
Who's trading ADMA
- Jerrold B Grossman, Insider: bought $251K (3 buys), last May 27, 2026
- Kaitlin M. Kestenberg-Messina, COO: sold $158K (1 sale), last Apr 1, 2026
- Lawrence P. Guiheen, Insider: other filings, last Mar 17, 2026
- Adam S Grossman, CEO: sold $1.7M (10 sales), last Mar 16, 2026
- Steve Elms, Insider: bought $217K (2 buys), last Mar 6, 2026
- Brad L. Tade, CFO: other filings, last Feb 19, 2026
- Young Kwon, Insider: other filings, last Feb 9, 2026
- Alison Cecily Finger, Insider: other filings, last Feb 9, 2026
- Eduardo Rene Salas, Insider: other filings, last Feb 9, 2026
Get free alerts when an insider at Adma Biologics, Inc files a new trade →